EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Fernando J Martinez iD, Alberto Papi iD, Tobias Welte iD, Dave Singh, Dmitry V Galkin, Alessandro Guasconi, Stefania Pirondi, George Georges iD, Joseph Imperato, Ruben Hermans

International Journal of Chronic Obstructive Pulmonary Disease · 2024-06 · Volume 19 · 1433-1445

DOI: 10.2147/copd.s451009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024-06. Verfasst von Fernando J Martinez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Disease, Chronic Obstructive, Disease Progression. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Chiesi Farmaceutici S.p.A., AstraZeneca, Chiesi Farmaceutici S.p.A., GSK and Sanofi/Regeneron, Agenzia Italiana del Farmaco (AIFA), and Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary Disease, Chronic ObstructiveDisease ProgressionHumansMaleFemaleAgedMiddle AgedSARS-CoV-2United StatesFranceUnited KingdomPandemicsItalyTime FactorsSeasons

Stichwörter der Autor:innen

COPD exacerbationCOVID-19chronic obstructive pulmonary diseaseelectronic health recordsreal-world study

Autor:innen und Institutionen

  • Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.
  • Research Center on Asthma and COPD, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Pneumonology and Infectiology, Member of the German Center of Lung Research, Hannover Medical School, Hannover, Germany.
  • Biomedical Research in End Stage and Obstructive Lung Disease, German Center for Lung Research, Hannover Medical School, Hannover, Germany.
  • Medicines Evaluations Unit, University of Manchester, Manchester University Foundation Hospitals Trust, Manchester, UK.
  • Global Clinical Development, Chiesi USA, Cary, NC, USA.

ORCID-Profile: Fernando J Martinez, Alberto Papi, Tobias Welte, George Georges

Förderung

  • Chiesi Farmaceutici S.p.A.
  • AstraZeneca, Chiesi Farmaceutici S.p.A., GSK and Sanofi/Regeneron
  • Agenzia Italiana del Farmaco (AIFA), and Sanofi
  • Berlin-Chemie

Zitieren

APA

Martinez, F. J., Papi, A., Welte, T., Singh, D., Galkin, D. V., Guasconi, A., Pirondi, S., Georges, G., Imperato, J., & Hermans, R. (2024). COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 1433-1445. https://doi.org/10.2147/copd.s451009

Vancouver

Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, et al. COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:1433-1445. doi:10.2147/copd.s451009

BibTeX
@article{Martinez2024,
  author = {Martinez, Fernando J and Papi, Alberto and Welte, Tobias and Singh, Dave and Galkin, Dmitry V and Guasconi, Alessandro and Pirondi, Stefania and Georges, George and Imperato, Joseph and Hermans, Ruben},
  title = {COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  volume = {Volume 19},
  pages = {1433--1445},
  doi = {10.2147/copd.s451009}
}
Kostenlos starten →